CN Patent
CN107428724A — 抗真菌化合物及制备方法
Assigned to Mycovia Pharmaceuticals Inc · Expires 2017-12-01 · 8y expired
What this patent protects
本发明涉及用作抗真菌剂的化合物1或1a的多晶型形式和用于制备化合物1和1a多晶型的方法。特别地,本发明寻求提供制备化合物1及其经取代的衍生物的多晶型的新方法。
USPTO Abstract
本发明涉及用作抗真菌剂的化合物1或1a的多晶型形式和用于制备化合物1和1a多晶型的方法。特别地,本发明寻求提供制备化合物1及其经取代的衍生物的多晶型的新方法。
Drugs covered by this patent
- Vivjoa (OTESECONAZOLE) · Mycovia Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.